These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1780188)

  • 1. Pyocin typing of Pseudomonas aeruginosa isolates from children with cystic fibrosis.
    Richardson CJ; Burke V; Bailey M; Fisher A
    Pathology; 1991 Jul; 23(3):229-32. PubMed ID: 1780188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Horrevorts AM; Borst J; Puyk RJ; De Ridder R; Dzoljicdanilovic G; Degener JE; Kerrebijn KF; Michel MF
    J Med Microbiol; 1990 Feb; 31(2):119-24. PubMed ID: 2106033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype and serum sensitivity of Pseudomonas aeruginosa from children with cystic fibrosis: longitudinal studies and typing with monoclonal antibodies.
    Burke V; Richardson CJ; Robinson J
    Pathology; 1990 Oct; 22(4):223-6. PubMed ID: 2128649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition in Biofilms between Cystic Fibrosis Isolates of
    Oluyombo O; Penfold CN; Diggle SP
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.
    Grothues D; Koopmann U; von der Hardt H; Tümmler B
    J Clin Microbiol; 1988 Oct; 26(10):1973-7. PubMed ID: 3141456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Spencker FB; Haupt S; Claros MC; Walter S; Lietz T; Schille R; Rodloff AC
    Clin Microbiol Infect; 2000 Nov; 6(11):600-7. PubMed ID: 11168063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Wolz C; Döring G; Lam JS; Rosdahl VT; Høiby N
    APMIS; 1990 May; 98(5):423-31. PubMed ID: 2113398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
    Mei M; Thomas J; Diggle SP
    mBio; 2021 May; 12(3):. PubMed ID: 33947755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases.
    Tredgett MW; Doherty C; Govan JR
    J Med Microbiol; 1990 Jul; 32(3):169-72. PubMed ID: 2115590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serotyping and pyocin typing of Pseudomonas aeruginosa in a study of intrahospital infections].
    Tomanović B; Joković B; Tatić M; Mirović V; Nanusević O
    Vojnosanit Pregl; 1991; 48(1):31-3. PubMed ID: 1905081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological typing of uropathogenic Pseudomonas aeruginosa strains from hospitalized patients.
    Visca P; Chiarini F; Vetriani C; Mansi A; Serino L; Orsi N
    J Hosp Infect; 1991 Nov; 19(3):153-65. PubMed ID: 1685503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Jun; 99(6):492-8. PubMed ID: 1905144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does pseudomonas cross-infection occur between cystic-fibrosis patients.
    Kelly NM; Fitzgerald MX; Tempany E; O'Boyle C; Falkiner FR; Keane CT
    Lancet; 1982 Sep; 2(8300):688-90. PubMed ID: 6126629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pyocin typing of Pseudomonas aeruginosa strains].
    Moroz AF; Petropavlovskaia IS; Osokina TI; Frolova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):31-5. PubMed ID: 6422681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pseudomonas pyocin typing method applicable to the clinical laboratory.
    Barnes WG; Gitta PS
    Am J Med Technol; 1979 Aug; 45(8):688-91. PubMed ID: 114048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.
    Köhler T; Donner V; van Delden C
    J Bacteriol; 2010 Apr; 192(7):1921-8. PubMed ID: 20118263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization by pyocine typing and serotyping of oral and sputum strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Komiyama K; Habbick BF; Martin T; Tumber SK
    Can J Microbiol; 1987 Mar; 33(3):221-5. PubMed ID: 3105857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagovar determination of Pseudomonas aeruginosa and a comparison of the results with mitomycin C induced pyocin production.
    Sticht-Groh V
    Zentralbl Bakteriol A; 1981; 249(2):225-34. PubMed ID: 6791406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.